Medical Care
Global Olfactory Neuroblastoma (ONB) Market Research Report 2025
- May 05, 25
- ID: 226577
- Pages: 74
- Figures: 72
- Views: 40
The global market for Olfactory Neuroblastoma (ONB) was valued at US$ 1300 million in the year 2024 and is projected to reach a revised size of US$ 2184 million by 2031, growing at a CAGR of 7.8% during the forecast period.
North American market for Olfactory Neuroblastoma (ONB) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Olfactory Neuroblastoma (ONB) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Olfactory Neuroblastoma (ONB) in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Olfactory Neuroblastoma (ONB) include Novartis, Bristol Myers Squibb, Merck, Pfizer, Astrazeneca, Abbvie, Eli Lilly, Amneal Pharmaceutical, Sanofi, Cadila Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Olfactory Neuroblastoma (ONB), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Olfactory Neuroblastoma (ONB).
The Olfactory Neuroblastoma (ONB) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Olfactory Neuroblastoma (ONB) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Olfactory Neuroblastoma (ONB) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Bristol Myers Squibb
Merck
Pfizer
Astrazeneca
Abbvie
Eli Lilly
Amneal Pharmaceutical
Sanofi
Cadila Pharmaceutical
Segment by Type
Chemotherapy
Immunotherapy
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Olfactory Neuroblastoma (ONB) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Olfactory Neuroblastoma (ONB) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Olfactory Neuroblastoma (ONB) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Olfactory Neuroblastoma (ONB) in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Olfactory Neuroblastoma (ONB) include Novartis, Bristol Myers Squibb, Merck, Pfizer, Astrazeneca, Abbvie, Eli Lilly, Amneal Pharmaceutical, Sanofi, Cadila Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Olfactory Neuroblastoma (ONB), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Olfactory Neuroblastoma (ONB).
The Olfactory Neuroblastoma (ONB) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Olfactory Neuroblastoma (ONB) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Olfactory Neuroblastoma (ONB) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Bristol Myers Squibb
Merck
Pfizer
Astrazeneca
Abbvie
Eli Lilly
Amneal Pharmaceutical
Sanofi
Cadila Pharmaceutical
Segment by Type
Chemotherapy
Immunotherapy
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Olfactory Neuroblastoma (ONB) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.3 Market by Application
1.3.1 Global Olfactory Neuroblastoma (ONB) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Olfactory Neuroblastoma (ONB) Market Perspective (2020-2031)
2.2 Global Olfactory Neuroblastoma (ONB) Growth Trends by Region
2.2.1 Global Olfactory Neuroblastoma (ONB) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Olfactory Neuroblastoma (ONB) Historic Market Size by Region (2020-2025)
2.2.3 Olfactory Neuroblastoma (ONB) Forecasted Market Size by Region (2026-2031)
2.3 Olfactory Neuroblastoma (ONB) Market Dynamics
2.3.1 Olfactory Neuroblastoma (ONB) Industry Trends
2.3.2 Olfactory Neuroblastoma (ONB) Market Drivers
2.3.3 Olfactory Neuroblastoma (ONB) Market Challenges
2.3.4 Olfactory Neuroblastoma (ONB) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Olfactory Neuroblastoma (ONB) Players by Revenue
3.1.1 Global Top Olfactory Neuroblastoma (ONB) Players by Revenue (2020-2025)
3.1.2 Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Players (2020-2025)
3.2 Global Olfactory Neuroblastoma (ONB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Olfactory Neuroblastoma (ONB) Revenue
3.4 Global Olfactory Neuroblastoma (ONB) Market Concentration Ratio
3.4.1 Global Olfactory Neuroblastoma (ONB) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Olfactory Neuroblastoma (ONB) Revenue in 2024
3.5 Global Key Players of Olfactory Neuroblastoma (ONB) Head office and Area Served
3.6 Global Key Players of Olfactory Neuroblastoma (ONB), Product and Application
3.7 Global Key Players of Olfactory Neuroblastoma (ONB), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Olfactory Neuroblastoma (ONB) Breakdown Data by Type
4.1 Global Olfactory Neuroblastoma (ONB) Historic Market Size by Type (2020-2025)
4.2 Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Type (2026-2031)
5 Olfactory Neuroblastoma (ONB) Breakdown Data by Application
5.1 Global Olfactory Neuroblastoma (ONB) Historic Market Size by Application (2020-2025)
5.2 Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
6.2 North America Olfactory Neuroblastoma (ONB) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025)
6.4 North America Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
7.2 Europe Olfactory Neuroblastoma (ONB) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025)
7.4 Europe Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
8.2 Asia-Pacific Olfactory Neuroblastoma (ONB) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size by Region (2020-2025)
8.4 Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
9.2 Latin America Olfactory Neuroblastoma (ONB) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025)
9.4 Latin America Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
10.2 Middle East & Africa Olfactory Neuroblastoma (ONB) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025)
10.4 Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Olfactory Neuroblastoma (ONB) Introduction
11.1.4 Novartis Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Details
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Olfactory Neuroblastoma (ONB) Introduction
11.2.4 Bristol Myers Squibb Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Olfactory Neuroblastoma (ONB) Introduction
11.3.4 Merck Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Olfactory Neuroblastoma (ONB) Introduction
11.4.4 Pfizer Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Astrazeneca
11.5.1 Astrazeneca Company Details
11.5.2 Astrazeneca Business Overview
11.5.3 Astrazeneca Olfactory Neuroblastoma (ONB) Introduction
11.5.4 Astrazeneca Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.5.5 Astrazeneca Recent Development
11.6 Abbvie
11.6.1 Abbvie Company Details
11.6.2 Abbvie Business Overview
11.6.3 Abbvie Olfactory Neuroblastoma (ONB) Introduction
11.6.4 Abbvie Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.6.5 Abbvie Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Olfactory Neuroblastoma (ONB) Introduction
11.7.4 Eli Lilly Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.7.5 Eli Lilly Recent Development
11.8 Amneal Pharmaceutical
11.8.1 Amneal Pharmaceutical Company Details
11.8.2 Amneal Pharmaceutical Business Overview
11.8.3 Amneal Pharmaceutical Olfactory Neuroblastoma (ONB) Introduction
11.8.4 Amneal Pharmaceutical Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.8.5 Amneal Pharmaceutical Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Olfactory Neuroblastoma (ONB) Introduction
11.9.4 Sanofi Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 Cadila Pharmaceutical
11.10.1 Cadila Pharmaceutical Company Details
11.10.2 Cadila Pharmaceutical Business Overview
11.10.3 Cadila Pharmaceutical Olfactory Neuroblastoma (ONB) Introduction
11.10.4 Cadila Pharmaceutical Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.10.5 Cadila Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.3 Market by Application
1.3.1 Global Olfactory Neuroblastoma (ONB) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Olfactory Neuroblastoma (ONB) Market Perspective (2020-2031)
2.2 Global Olfactory Neuroblastoma (ONB) Growth Trends by Region
2.2.1 Global Olfactory Neuroblastoma (ONB) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Olfactory Neuroblastoma (ONB) Historic Market Size by Region (2020-2025)
2.2.3 Olfactory Neuroblastoma (ONB) Forecasted Market Size by Region (2026-2031)
2.3 Olfactory Neuroblastoma (ONB) Market Dynamics
2.3.1 Olfactory Neuroblastoma (ONB) Industry Trends
2.3.2 Olfactory Neuroblastoma (ONB) Market Drivers
2.3.3 Olfactory Neuroblastoma (ONB) Market Challenges
2.3.4 Olfactory Neuroblastoma (ONB) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Olfactory Neuroblastoma (ONB) Players by Revenue
3.1.1 Global Top Olfactory Neuroblastoma (ONB) Players by Revenue (2020-2025)
3.1.2 Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Players (2020-2025)
3.2 Global Olfactory Neuroblastoma (ONB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Olfactory Neuroblastoma (ONB) Revenue
3.4 Global Olfactory Neuroblastoma (ONB) Market Concentration Ratio
3.4.1 Global Olfactory Neuroblastoma (ONB) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Olfactory Neuroblastoma (ONB) Revenue in 2024
3.5 Global Key Players of Olfactory Neuroblastoma (ONB) Head office and Area Served
3.6 Global Key Players of Olfactory Neuroblastoma (ONB), Product and Application
3.7 Global Key Players of Olfactory Neuroblastoma (ONB), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Olfactory Neuroblastoma (ONB) Breakdown Data by Type
4.1 Global Olfactory Neuroblastoma (ONB) Historic Market Size by Type (2020-2025)
4.2 Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Type (2026-2031)
5 Olfactory Neuroblastoma (ONB) Breakdown Data by Application
5.1 Global Olfactory Neuroblastoma (ONB) Historic Market Size by Application (2020-2025)
5.2 Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
6.2 North America Olfactory Neuroblastoma (ONB) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025)
6.4 North America Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
7.2 Europe Olfactory Neuroblastoma (ONB) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025)
7.4 Europe Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
8.2 Asia-Pacific Olfactory Neuroblastoma (ONB) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size by Region (2020-2025)
8.4 Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
9.2 Latin America Olfactory Neuroblastoma (ONB) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025)
9.4 Latin America Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size (2020-2031)
10.2 Middle East & Africa Olfactory Neuroblastoma (ONB) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025)
10.4 Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Olfactory Neuroblastoma (ONB) Introduction
11.1.4 Novartis Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Details
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb Olfactory Neuroblastoma (ONB) Introduction
11.2.4 Bristol Myers Squibb Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Olfactory Neuroblastoma (ONB) Introduction
11.3.4 Merck Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Olfactory Neuroblastoma (ONB) Introduction
11.4.4 Pfizer Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Astrazeneca
11.5.1 Astrazeneca Company Details
11.5.2 Astrazeneca Business Overview
11.5.3 Astrazeneca Olfactory Neuroblastoma (ONB) Introduction
11.5.4 Astrazeneca Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.5.5 Astrazeneca Recent Development
11.6 Abbvie
11.6.1 Abbvie Company Details
11.6.2 Abbvie Business Overview
11.6.3 Abbvie Olfactory Neuroblastoma (ONB) Introduction
11.6.4 Abbvie Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.6.5 Abbvie Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Olfactory Neuroblastoma (ONB) Introduction
11.7.4 Eli Lilly Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.7.5 Eli Lilly Recent Development
11.8 Amneal Pharmaceutical
11.8.1 Amneal Pharmaceutical Company Details
11.8.2 Amneal Pharmaceutical Business Overview
11.8.3 Amneal Pharmaceutical Olfactory Neuroblastoma (ONB) Introduction
11.8.4 Amneal Pharmaceutical Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.8.5 Amneal Pharmaceutical Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Olfactory Neuroblastoma (ONB) Introduction
11.9.4 Sanofi Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 Cadila Pharmaceutical
11.10.1 Cadila Pharmaceutical Company Details
11.10.2 Cadila Pharmaceutical Business Overview
11.10.3 Cadila Pharmaceutical Olfactory Neuroblastoma (ONB) Introduction
11.10.4 Cadila Pharmaceutical Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025)
11.10.5 Cadila Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Immunotherapy
Table 4. Global Olfactory Neuroblastoma (ONB) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Olfactory Neuroblastoma (ONB) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Olfactory Neuroblastoma (ONB) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Olfactory Neuroblastoma (ONB) Market Share by Region (2020-2025)
Table 8. Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Olfactory Neuroblastoma (ONB) Market Share by Region (2026-2031)
Table 10. Olfactory Neuroblastoma (ONB) Market Trends
Table 11. Olfactory Neuroblastoma (ONB) Market Drivers
Table 12. Olfactory Neuroblastoma (ONB) Market Challenges
Table 13. Olfactory Neuroblastoma (ONB) Market Restraints
Table 14. Global Olfactory Neuroblastoma (ONB) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Olfactory Neuroblastoma (ONB) Market Share by Players (2020-2025)
Table 16. Global Top Olfactory Neuroblastoma (ONB) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olfactory Neuroblastoma (ONB) as of 2024)
Table 17. Ranking of Global Top Olfactory Neuroblastoma (ONB) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Olfactory Neuroblastoma (ONB) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Olfactory Neuroblastoma (ONB), Headquarters and Area Served
Table 20. Global Key Players of Olfactory Neuroblastoma (ONB), Product and Application
Table 21. Global Key Players of Olfactory Neuroblastoma (ONB), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Olfactory Neuroblastoma (ONB) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Type (2020-2025)
Table 25. Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Type (2026-2031)
Table 27. Global Olfactory Neuroblastoma (ONB) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Application (2020-2025)
Table 29. Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Application (2026-2031)
Table 31. North America Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novartis Company Details
Table 47. Novartis Business Overview
Table 48. Novartis Olfactory Neuroblastoma (ONB) Product
Table 49. Novartis Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Bristol Myers Squibb Company Details
Table 52. Bristol Myers Squibb Business Overview
Table 53. Bristol Myers Squibb Olfactory Neuroblastoma (ONB) Product
Table 54. Bristol Myers Squibb Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 55. Bristol Myers Squibb Recent Development
Table 56. Merck Company Details
Table 57. Merck Business Overview
Table 58. Merck Olfactory Neuroblastoma (ONB) Product
Table 59. Merck Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Olfactory Neuroblastoma (ONB) Product
Table 64. Pfizer Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Astrazeneca Company Details
Table 67. Astrazeneca Business Overview
Table 68. Astrazeneca Olfactory Neuroblastoma (ONB) Product
Table 69. Astrazeneca Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 70. Astrazeneca Recent Development
Table 71. Abbvie Company Details
Table 72. Abbvie Business Overview
Table 73. Abbvie Olfactory Neuroblastoma (ONB) Product
Table 74. Abbvie Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 75. Abbvie Recent Development
Table 76. Eli Lilly Company Details
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly Olfactory Neuroblastoma (ONB) Product
Table 79. Eli Lilly Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 80. Eli Lilly Recent Development
Table 81. Amneal Pharmaceutical Company Details
Table 82. Amneal Pharmaceutical Business Overview
Table 83. Amneal Pharmaceutical Olfactory Neuroblastoma (ONB) Product
Table 84. Amneal Pharmaceutical Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 85. Amneal Pharmaceutical Recent Development
Table 86. Sanofi Company Details
Table 87. Sanofi Business Overview
Table 88. Sanofi Olfactory Neuroblastoma (ONB) Product
Table 89. Sanofi Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 90. Sanofi Recent Development
Table 91. Cadila Pharmaceutical Company Details
Table 92. Cadila Pharmaceutical Business Overview
Table 93. Cadila Pharmaceutical Olfactory Neuroblastoma (ONB) Product
Table 94. Cadila Pharmaceutical Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 95. Cadila Pharmaceutical Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Olfactory Neuroblastoma (ONB) Picture
Figure 2. Global Olfactory Neuroblastoma (ONB) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Olfactory Neuroblastoma (ONB) Market Share by Type: 2024 VS 2031
Figure 4. Chemotherapy Features
Figure 5. Immunotherapy Features
Figure 6. Global Olfactory Neuroblastoma (ONB) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Olfactory Neuroblastoma (ONB) Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Olfactory Neuroblastoma (ONB) Report Years Considered
Figure 11. Global Olfactory Neuroblastoma (ONB) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Olfactory Neuroblastoma (ONB) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Olfactory Neuroblastoma (ONB) Market Share by Region: 2024 VS 2031
Figure 14. Global Olfactory Neuroblastoma (ONB) Market Share by Players in 2024
Figure 15. Global Top Olfactory Neuroblastoma (ONB) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olfactory Neuroblastoma (ONB) as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Olfactory Neuroblastoma (ONB) Revenue in 2024
Figure 17. North America Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Olfactory Neuroblastoma (ONB) Market Share by Country (2020-2031)
Figure 19. United States Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Olfactory Neuroblastoma (ONB) Market Share by Country (2020-2031)
Figure 23. Germany Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Share by Region (2020-2031)
Figure 31. China Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Olfactory Neuroblastoma (ONB) Market Share by Country (2020-2031)
Figure 39. Mexico Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Share by Country (2020-2031)
Figure 43. Turkey Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 47. Bristol Myers Squibb Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 48. Merck Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 50. Astrazeneca Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 51. Abbvie Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 52. Eli Lilly Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 53. Amneal Pharmaceutical Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 54. Sanofi Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 55. Cadila Pharmaceutical Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Immunotherapy
Table 4. Global Olfactory Neuroblastoma (ONB) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Olfactory Neuroblastoma (ONB) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Olfactory Neuroblastoma (ONB) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Olfactory Neuroblastoma (ONB) Market Share by Region (2020-2025)
Table 8. Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Olfactory Neuroblastoma (ONB) Market Share by Region (2026-2031)
Table 10. Olfactory Neuroblastoma (ONB) Market Trends
Table 11. Olfactory Neuroblastoma (ONB) Market Drivers
Table 12. Olfactory Neuroblastoma (ONB) Market Challenges
Table 13. Olfactory Neuroblastoma (ONB) Market Restraints
Table 14. Global Olfactory Neuroblastoma (ONB) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Olfactory Neuroblastoma (ONB) Market Share by Players (2020-2025)
Table 16. Global Top Olfactory Neuroblastoma (ONB) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olfactory Neuroblastoma (ONB) as of 2024)
Table 17. Ranking of Global Top Olfactory Neuroblastoma (ONB) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Olfactory Neuroblastoma (ONB) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Olfactory Neuroblastoma (ONB), Headquarters and Area Served
Table 20. Global Key Players of Olfactory Neuroblastoma (ONB), Product and Application
Table 21. Global Key Players of Olfactory Neuroblastoma (ONB), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Olfactory Neuroblastoma (ONB) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Type (2020-2025)
Table 25. Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Type (2026-2031)
Table 27. Global Olfactory Neuroblastoma (ONB) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Application (2020-2025)
Table 29. Global Olfactory Neuroblastoma (ONB) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Olfactory Neuroblastoma (ONB) Revenue Market Share by Application (2026-2031)
Table 31. North America Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novartis Company Details
Table 47. Novartis Business Overview
Table 48. Novartis Olfactory Neuroblastoma (ONB) Product
Table 49. Novartis Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Bristol Myers Squibb Company Details
Table 52. Bristol Myers Squibb Business Overview
Table 53. Bristol Myers Squibb Olfactory Neuroblastoma (ONB) Product
Table 54. Bristol Myers Squibb Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 55. Bristol Myers Squibb Recent Development
Table 56. Merck Company Details
Table 57. Merck Business Overview
Table 58. Merck Olfactory Neuroblastoma (ONB) Product
Table 59. Merck Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Olfactory Neuroblastoma (ONB) Product
Table 64. Pfizer Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Astrazeneca Company Details
Table 67. Astrazeneca Business Overview
Table 68. Astrazeneca Olfactory Neuroblastoma (ONB) Product
Table 69. Astrazeneca Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 70. Astrazeneca Recent Development
Table 71. Abbvie Company Details
Table 72. Abbvie Business Overview
Table 73. Abbvie Olfactory Neuroblastoma (ONB) Product
Table 74. Abbvie Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 75. Abbvie Recent Development
Table 76. Eli Lilly Company Details
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly Olfactory Neuroblastoma (ONB) Product
Table 79. Eli Lilly Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 80. Eli Lilly Recent Development
Table 81. Amneal Pharmaceutical Company Details
Table 82. Amneal Pharmaceutical Business Overview
Table 83. Amneal Pharmaceutical Olfactory Neuroblastoma (ONB) Product
Table 84. Amneal Pharmaceutical Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 85. Amneal Pharmaceutical Recent Development
Table 86. Sanofi Company Details
Table 87. Sanofi Business Overview
Table 88. Sanofi Olfactory Neuroblastoma (ONB) Product
Table 89. Sanofi Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 90. Sanofi Recent Development
Table 91. Cadila Pharmaceutical Company Details
Table 92. Cadila Pharmaceutical Business Overview
Table 93. Cadila Pharmaceutical Olfactory Neuroblastoma (ONB) Product
Table 94. Cadila Pharmaceutical Revenue in Olfactory Neuroblastoma (ONB) Business (2020-2025) & (US$ Million)
Table 95. Cadila Pharmaceutical Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Olfactory Neuroblastoma (ONB) Picture
Figure 2. Global Olfactory Neuroblastoma (ONB) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Olfactory Neuroblastoma (ONB) Market Share by Type: 2024 VS 2031
Figure 4. Chemotherapy Features
Figure 5. Immunotherapy Features
Figure 6. Global Olfactory Neuroblastoma (ONB) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Olfactory Neuroblastoma (ONB) Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Olfactory Neuroblastoma (ONB) Report Years Considered
Figure 11. Global Olfactory Neuroblastoma (ONB) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Olfactory Neuroblastoma (ONB) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Olfactory Neuroblastoma (ONB) Market Share by Region: 2024 VS 2031
Figure 14. Global Olfactory Neuroblastoma (ONB) Market Share by Players in 2024
Figure 15. Global Top Olfactory Neuroblastoma (ONB) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olfactory Neuroblastoma (ONB) as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Olfactory Neuroblastoma (ONB) Revenue in 2024
Figure 17. North America Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Olfactory Neuroblastoma (ONB) Market Share by Country (2020-2031)
Figure 19. United States Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Olfactory Neuroblastoma (ONB) Market Share by Country (2020-2031)
Figure 23. Germany Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Olfactory Neuroblastoma (ONB) Market Share by Region (2020-2031)
Figure 31. China Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Olfactory Neuroblastoma (ONB) Market Share by Country (2020-2031)
Figure 39. Mexico Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Olfactory Neuroblastoma (ONB) Market Share by Country (2020-2031)
Figure 43. Turkey Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Olfactory Neuroblastoma (ONB) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 47. Bristol Myers Squibb Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 48. Merck Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 50. Astrazeneca Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 51. Abbvie Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 52. Eli Lilly Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 53. Amneal Pharmaceutical Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 54. Sanofi Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 55. Cadila Pharmaceutical Revenue Growth Rate in Olfactory Neuroblastoma (ONB) Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232